Resolv ER

Resolv ER is an investigational **intravitreal liposomal urea formulation** being developed by China Ophthalmology Focus for **vitreomacular traction**. It is described by the company as an intravitreal injection of **liposome-loaded urea**, in which urea solution is encapsulated in biodegradable, biocompatible liposomes to provide **sustained release** in the vitreous. The therapeutic concept is to pharmacologically reduce vitreomacular adhesion and potentially allow patients with vitreomacular traction to avoid invasive surgery while preserving vision. Public company materials indicate the program is in **IND-enabling / in development** rather than clinical-stage development.

Other names

liposome-loaded urea intravitreal injectionliposome-encapsulated urea intravitreal injection